Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ALD
WisdomTree Asia Local Debt Fund
$44.39
-0.2%
$44.39
$41.78
$46.65
$17.76MN/A7,986 shs1,400 shs
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
C$0.43
-2.3%
C$0.42
C$0.36
C$0.73
C$8.40M1.6617,152 shs4,515 shs
Ampol Limited stock logo
CTXAF
Ampol
$24.75
$24.66
$19.91
$24.75
N/AN/A600 shsN/A
Idemitsu Kosan Co.,Ltd. stock logo
IDKOY
Idemitsu Kosan Co.,Ltd.
$13.00
$13.29
$8.03
$14.40
N/AN/A2,664 shsN/A
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ALD
WisdomTree Asia Local Debt Fund
0.00%0.00%0.00%0.00%0.00%
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
0.00%+4.76%+2.33%-18.52%-33.33%
Ampol Limited stock logo
CTXAF
Ampol
+3.27%0.00%0.00%+8.08%+19.77%
Idemitsu Kosan Co.,Ltd. stock logo
IDKOY
Idemitsu Kosan Co.,Ltd.
0.00%-0.91%-7.80%+17.22%+528.63%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ALD
WisdomTree Asia Local Debt Fund
N/AN/AN/AN/AN/AN/AN/AN/A
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Ampol Limited stock logo
CTXAF
Ampol
N/AN/AN/AN/AN/AN/AN/AN/A
Idemitsu Kosan Co.,Ltd. stock logo
IDKOY
Idemitsu Kosan Co.,Ltd.
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ALD
WisdomTree Asia Local Debt Fund
0.00
N/AN/AN/A
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
N/AN/AN/AN/A
Ampol Limited stock logo
CTXAF
Ampol
3.00
BuyN/AN/A
Idemitsu Kosan Co.,Ltd. stock logo
IDKOY
Idemitsu Kosan Co.,Ltd.
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ALD
WisdomTree Asia Local Debt Fund
N/AN/AN/AN/AN/AN/A
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
C$17.52M0.48C$0.36 per share1.20C$0.94 per share0.46
Ampol Limited stock logo
CTXAF
Ampol
N/AN/AN/AN/AN/AN/A
Idemitsu Kosan Co.,Ltd. stock logo
IDKOY
Idemitsu Kosan Co.,Ltd.
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ALD
WisdomTree Asia Local Debt Fund
N/AN/A0.00N/AN/AN/AN/AN/A
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
-C$1.99M-C$0.10N/AN/A-11.33%-9.95%-4.61%5/9/2024 (Estimated)
Ampol Limited stock logo
CTXAF
Ampol
N/A$1.8413.43N/AN/AN/AN/AN/A
Idemitsu Kosan Co.,Ltd. stock logo
IDKOY
Idemitsu Kosan Co.,Ltd.
N/A$50.830.26N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ALD
WisdomTree Asia Local Debt Fund
$0.942.12%N/AN/AN/A
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
N/AN/AN/AN/AN/A
Ampol Limited stock logo
CTXAF
Ampol
$0.170.69%N/A9.22%N/A
Idemitsu Kosan Co.,Ltd. stock logo
IDKOY
Idemitsu Kosan Co.,Ltd.
$11.2586.56%N/A22.14%N/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ALD
WisdomTree Asia Local Debt Fund
N/AN/AN/A
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
6.66
3.80
2.29
Ampol Limited stock logo
CTXAF
Ampol
N/AN/AN/A
Idemitsu Kosan Co.,Ltd. stock logo
IDKOY
Idemitsu Kosan Co.,Ltd.
N/AN/AN/A

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
ALD
WisdomTree Asia Local Debt Fund
N/A400,000N/ANot Optionable
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
6219.54 millionN/ANot Optionable
Ampol Limited stock logo
CTXAF
Ampol
3,152N/AN/ANot Optionable
Idemitsu Kosan Co.,Ltd. stock logo
IDKOY
Idemitsu Kosan Co.,Ltd.
14,363N/AN/ANot Optionable

IDKOY, ALD, CTXAF, and CTX Headlines

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

WisdomTree Asia Local Debt Fund

NYSEARCA:ALD
Crescita Therapeutics logo

Crescita Therapeutics

TSE:CTX
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp. The company's prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermatological procedures; CTX-101, a Phase III topical formulation utilizing a corticosteroid in combination with MMPE technology to treat plaque psoriasis; CTX-102, a Phase I topical formulation utilizing MMPE technology to treat an undisclosed dermatological skin condition; and dermatology products in pre-clinical formulation utilizing MMPE technology for prescription treatments of skin diseases. Its non-prescription portfolio offers dermocosmetic products, such as facial creams, cleansers, exfoliants, masks, serums, and suncare to treat mild acne, aging, dehydration, pigmentation, sensitivity, and rosacea under the Laboratoire Dr Renaud brand; and provides medical aesthetics under Pro-Derm and Alyria brands, for non-invasive and minimally invasive procedures or skincare treatments. In addition, it distributes NCTF Boost 135 HA, a skin revitalization solution; Obagi Medical products; and ART FILLER, hyaluronic acid-based dermal fillers. The company has a commercialization license agreement with Cantabria Labs Inc.; and a development and commercialization license agreement with Taro Pharmaceuticals Inc. Crescita Therapeutics Inc. was incorporated in 2016 and is headquartered in Laval, Canada.
Ampol logo

Ampol

OTCMKTS:CTXAF
Ampol Limited purchases, refines, distributes, and markets petroleum products in Australia, New Zealand, Singapore, and the United States. The company operates through Convenience Retail, Z Energy, and Fuels and Infrastructure segments. The Convenience Retail segment sells fuels through Ampol's network of stores. The Fuels and Infrastructure segment wholesales fuels and lubricant supplies. The Z Energy segment distributes fuel in the New Zealand market. It distributes its products through depots, terminals, pipelines, and service station sites. The company sells fuels to various customers in defense, mining, transport, marine, agriculture, aviation, and other commercial and industrial sectors. The company was formerly known as Caltex Australia Limited and changed its name to Ampol Limited in May 2020. The company was founded in 1900 and is headquartered in Alexandria, Australia.
Idemitsu Kosan Co.,Ltd. logo

Idemitsu Kosan Co.,Ltd.

OTCMKTS:IDKOY
Idemitsu Kosan Co.,Ltd. engages in the petroleum, basic chemicals, functional materials, power and renewable energy, and resources businesses in Japan and internationally. The company's Petroleum segment engages in the procurement of crude oil and refining of petroleum products; sale of gasoline, diesel oil, kerosene, automotive lubricants, industrial kerosene, heavy oil, and aviation and marine fuel; and operation of hydrogen stations. Its Basic Chemicals segment manufactures and sells olefins, such as ethylene, propylene, and butadiene; aromatics, including benzene, styrene monomer, mixed xylene, and paraxylene; and other chemicals. The company's Functional Materials segment researches, develops, manufactures, and sells automotive, industrial, and marine lubricants, as well as grease; engineering plastic, adhesive materials, derivative products, and solvents; electronic materials, such as OLED; asphalt; microbial pesticides, soil amendments, and livestock related materials; and solid state lithium ion battery materials. Its Power and Renewable Energy segment operates thermal power plants; develops and operates renewable energy sources, including solar, wind, and biomass power plants; engages in the supply, wholesale, and retail of electric power; researches, develops, and manufactures CIS thin-film solar modules; and sells solar power systems. The company's Resources segments explores, develops, and produces oil and gas; produces and sells coal and uranium; operates geothermal power plants; and sale of electric power and steam. Idemitsu Kosan Co.,Ltd. was founded in 1911 and is headquartered in Tokyo, Japan.